Company: American Commercialization Institute
Liaison(s): Michael Gitelmaker
Chronic back pain affects millions of people worldwide. Back surgery is invasive, painful and requires a significant period for recovery. ACI is developing a non-invasive laser technology for regeneration of cartilage in destroyed and damaged spinal disks and has conducted successful clinical trials in Russia. The KGI team has been focusing on creating ACI’s business plan, seeking additional funding to develop the technology, devising a strategy for intellectual property positioning, and assessing potential markets. They are also investigating possible strategies for design of further clinical trials.